Clinical Trial Update: Single Subject Neratinib in Bladder Cancer (NRR)

View source ↗

Summary

A single-subject clinical trial of neratinib in bladder cancer has been updated and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• neratinib (neratinib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Bladder Cancer | Status: NO_LONGER_AVAILABLE